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Lithium is a drug used to treat mood disorders and also has many side effects, 
including central nervous system (CNS) complications (such as cognitive dulling), 
associated with its use. The mechanism of its action still remains unknown. Over the 
years, many leads have started emerging. It has been shown to inhibit several 
enzymes in the cell and has been implicated in altering many neurotransmitter 
systems and signal transduction pathways (serotonin, dopamine and norepinephrine 
neurotransmissions). Effect of exposure to therapeutic levels of lithium on mature 
glutamatergic synapses is being studied and several changes in glutamate receptor 
subtypes have already been reported. Effects of lithium on developing glutamatergic 
synapses have not been studied. The thesis tries to document and understand the 
changes brought about by long term lithium treatment on developing glutamatergic 
synapses in vitro in hippocampal neuronal cultures. In the present work, patch clamp 
technique was used to monitor the changes in the postsynapse and fluorescence 
imaging to study the presynaptic changes.  
The hippocampal neuronal cultures were treated with 1 mM lithium for 6 days during 
the synaptogenesis stage (DIV 4-10) and termed as chronic Li treatment (CLi).  
Following CLi treatment the changes occurring in amplitude and rectification 
property of the AMPA receptor (AMPAR), a subtype of glutamate ionotropic  
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receptor,  mediated  miniature excitatory postsynaptic currents (mEPSCs) have been 
reported (Chapter III). Lithium inhibits protein kinase A (PKA), glycogen synthase 
kinase–3β (GSK-3β) and glutamate reuptake. Effect of inhibiting PKA, GSK-3β and 
glutamate reuptake was also studied with a view to understand the molecular basis of 
lithium action on AMPAR mEPSCs (Chapter IV).  
It was found that chronic lithium treatment (CLi) caused a reduction in the mean 
amplitude of mEPSCs mediated by AMPARs and also changed the rectification 
property of these receptors from being more outwardly rectifying to being more 
inwardly rectifying, an indication probably of increase in contribution of Ca
2+
-
permeable AMPARs to the synaptic events.  AMPAR events in chronic lithium 
treated cultures were more sensitive to both N-acetyl spermine (NASPM) application 
and di-fluoro-methyl-ornithine (DFMO) treatment, both specific to Ca
2+
-permeable 
AMPARs, indicating that there was an increase in the contribution from Ca
2+
-
permeable AMPARs to the synaptic events.  
PKA inhibition with H-89 treatment (starting from DIV 4 (for 6 days))  reduced the 
mean amplitude of AMPAR mEPSCs  and  increased the mean rectification index 
(RI). GSK-3β inhibition with SB415286 (starting from DIV 4 (for 6 days)) did not 
alter the mean mEPSC amplitude but reduced the mean RI. Transient (24 hrs) 
glutamate reuptake inhibition with threo-β-Hydroxy-Aspartic-Acid (THA) at DIV 4 
followed by a period of recovery led to smaller amplitudes but no change in RI. The 
24 hr glutamate reuptake block on DIV 4 had long term effects. It led to an increase 
in AMPAR mEPSC frequency while AMPAR  mEPSC amplitudes were reduced. The 
mean RI decrease seen when glutamate reuptake was blocked for 24 hrs on DIV 10, 
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was absent in DIV 4 THA treated neurons. However, when the neuronal cultures 
were maintained in the presence of PKA and GSK-3β inhibitors, the DIV 4 THA 
treated neurons showed AMPAR mEPSC characteristics similar to CLi neurons. 
Thus, it was seen that individual inhibition of PKA, GSK-3β and glutamate reuptake 
did not lead to changes in AMPAR mEPSCs similar to that seen in lithium treated 
neurons. The effect of lithium exposure during synapse development on AMPARs 
could be reproduced closely by co-inhibiting PKA, GSK-3β and glutamate reuptake. 
Using the styryl dye FM1-43, the changes induced in presynaptic release by a similar 
chronic lithium treatment was studied (Chapter V). It was found that lithium 
exposure (1 mM, DIV 4-10) brought down the extent of dye loading, destaining and 
also slowed down the rate of dye loss in response to high KCl stimulation (the τfast 
component of destaining was significantly slower). Minimum loading experiments 
did not reveal any difference in mode of exocytosis (kiss and run/full-collapse) in 
control and lithium treated cultures. Chlorpromazine treatment (that inhibits clathrin-
mediated endocytosis) affected dye loading to a lesser extent in lithium treated 
cultures as compared to control.  Surprisingly, exposure to hyperosmotic solution 10 
minutes after dye wash out boosted the extent of dye loading and destaining in 
lithium treated cultures (a phenomenon not seen in control). This could happen if the 
FM1-43 is trapped away from the wash solution during the wash period. This would 
be possible if endocytosis in CLi takes place, differently from control, through a 
process involving membrane infoldings similar to bulk endocytosis albeit a 
slower/compromised one. Taken together, the data presented here indicates that 
lithium treatment during synaptogenesis affects vesicular recycling mostly at the 
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endocytosis and docking/priming steps (mobilization of vesicles for release). Lithium 
treated cultures also did not show the high KCl associated presynaptic potentiation 
observed in control which is a significant finding. 
In conclusion, chronic lithium treatment affected both the presynaptic and 
postsynaptic compartments of the glutamatergic synapse. The effect of lithium on 
AMPAR mEPSC could not be reproduced by individual inhibitions of biochemical 
effectors but by multiple inhibitions. Thus, the study done here underscores the need 
to look at the manifold effect of lithium in an integrated way. The study also might 
have implications in understanding the CNS complications seen in patients taking 
lithium treatment and in babies perinatally exposed to lithium. 
 
